Dr. Christine E. Seidman M.D. serves as Independent Director of the Company. Dr. Seidman has extensive scientific experience relevant to the biopharmaceutical industry, including being the Thomas W. Smith Professor of Medicine and Genetics at Harvard Medical School and the director of the Cardiovascular Genetics Center. In addition, her role leading the Seidman Laboratory, a research laboratory that focuses on integrating clinical medicine and molecular technologies to define disease-causing gene mutations and genetic variations that increase disease risk, provides Dr. Seidman with managerial experience relevant to scientific research. The recipient of many honors, Dr. Seidman was elected to the American Society for Clinical Investigation, the National Academy of Sciences, American Academy of Arts and Sciences and the National Academy of Medicine. Harvard Medical School/Brigham and Women’s Hospital (Harvard University) ?Thomas W. Smith Professor of Medicine and Genetics (2005-present)?Professor of Genetics and Medicine (1998-2005) Professor of Medicine (1997-1998) Howard Hughes Medical Institute, non-profit medical research organization?Investigator (1994-present) Brigham and Women’s Hospital Director, Cardiovascular Genetics Center (1992-present) ?Attending Physician, Cardiovascular Division (1987-present).
Christine Seidman is 67, he's been the Independent Director of Merck & Co Inc since 2020. There are 4 older and 22 younger executives at Merck & Co Inc. The oldest executive at Merck & Co Inc is Thomas Cech, 73, who is the Independent Director.
Christine's mailing address filed with the SEC is MERCK & CO., INC., 126 EAST LINCOLN AVENUE, RAHWAY, NJ, 07065.
Over the last 15 years, insiders at Merck & Co Inc have traded over $138,980,380 worth of Merck & Co Inc stock and bought 48,209 units worth $1,563,736 . The most active insiders traders include Wendell P Weeks, Kenneth C Frazier, eDouglas M Jr Baker. On average, Merck & Co Inc executives and independent directors trade stock every 15 days with the average trade being worth of $5,050,222. The most recent stock trade was executed by Chirfi Guindo on 5 August 2024, trading 36,901 units of MRK stock currently worth $4,250,995.
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.
Merck & Co Inc executives and other stock owners filed with the SEC include: